Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D Molecular, Acelrx, Albireo, Biolinerx, Epitopoietic Research, Jaguar Health, Kamada, Merck, Northwest, PCI, Pluristem, Qu, Trefoil, Turning Point, Verona.